HAEMONETICS CORP/MASSHAE
ASignal's systematic analysis rates HAE as Neutral.
Reflects the latest available analysis · analyzed Oct 9, 2026
The case on HAE
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Price above 20-day and 50-day moving averages indicating uptrend
- Positive MACD histogram showing strengthening momentum
- Strong gross margin of 59.33% indicating pricing power
- Operating cash flow of $328.15M supports operational stability
- Current ratio of 3.08x reflects solid short-term financial health
- RSI at 68.78 approaching overbought territory
- High P/E ratio of 57.43x relative to earnings growth
- Debt-to-equity ratio of 1.40x above ideal threshold of 1.0
- PEG ratio of 1.89x suggests overvaluation relative to growth
See the full verdict on HAE
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes HAE
Most investors never get a second opinion, let alone several. ASignal runs HAE past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.